According to the schedule on SNDY's website, everything is

New Post Public Reply Private Reply Replies (0) Message Board
blueskies
According to the schedule on SNDY's website, everything is on track just as they said.
http://www.solosendoscopy.com/press-releases/...e-2013.pdf
#23 - August 16 was the scheduled Stage 2 Audit... COMPLETED
#23 also includes #13, #15 & #16 reviews ... .
#15 .... bare with me...includes Implement Other New Systems INCLUDING CAPA's
(CAPA's - Corrective and Preventative Actions)
so..
MAYBE #23 will happen BEFORE the holiday weekend.......??  Recieving the actual certifications........again I am only saying this because they have been 'on-point' with the most current schedule AND that schedule does end BEFORE September begins....there are some big name companies involved with reputations and guarantees here... 

"We consider it our responsibility to help you achieve ISO 13485:2003 certification as soon as possible " - Emergo Group website

An official release of the actual certification before a long weekend would be HUGE

Bob mentions the in the latest release "The Company expects the entire process to be concluded by the end of the year, which will allow the Company to market and sell its instruments internationally in 2014."

Could the 'entire process'  mean more?  Like an announcement of acquisition/partner/merger?  So that when 2014 begins, they can jump right in and waste no time selling?

Just making conversation
Good Luck
blueskies

We consider it our responsibility to help you achieve ISO 13485:2003 certification as soon as possible, maintain compliance over the long term and do so in a way that has minimal impact on your business. - See more at: http://www.iso13485.com/time-to-implement-iso...aBwvD.dpuf
We consider it our responsibility to help you achieve ISO 13485:2003 certification as soon as possible, maintain compliance over the long term and do so in a way that has minimal impact on your business. - See more at: http://www.iso13485.com/time-to-implement-iso...aBwvD.dpuf

CYduct Diagnostics Inc. (CYDX) Stock Research Links

CYDX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

USDA Under Scrutiny as ASPCA Reports on Puppy Mill Violations

Updated Category News Views 322

ASPCA's Shocking Report on Puppy Mill Violations In a recent analysis by the ASPCA, alarming statistics have surfaced regarding animal welfare violations at USDA-licensed commercial dog breeding facilities. The findings reveal that in a given year, substantial breaches of care standards were documented, yet no actions were taken to ensure the safety of the animals....

Continue Reading
PowerReviews Unveils Partner Program to Amplify UGC Value

Updated Category News Views 1653

PowerReviews Launches Comprehensive Partner Program PowerReviews, a reputable name backed by 1WorldSync, has initiated an exciting Partner Program aimed at revolutionizing the way user-generated content (UGC) is leveraged. This initiative is designed to not only boost productivity but also facilitate enhanced revenue opportunities for partners who promote its advanced...

Continue Reading
Turnspire Capital Partners Expands Portfolio with GHP Group

Updated Category News Views 81

Turnspire Capital Partners pulled the trigger on acquiring GHP Group back in 2024, a move that sent shockwaves through the consumer product landscape. This was no random buy; GHP's got its fingers in the pie of outdoor living products—think patio heaters and grills—all under reputable brands like Dyna-Glo and Pleasant Hearth. GHP Group: A Heavyweight Player in Outdoor...

Continue Reading
MPI Corporation Launches Groundbreaking 250 GHz Probe System

Updated Category News Views 187

Enhancing Precision in Semiconductor Testing In the fast-evolving world of semiconductor technology, precision and performance are critical. MPI Corporation has once again demonstrated its innovative spirit by unveiling a revolutionary 250 GHz broadband test solution. This state-of-the-art system combines the power of the TITAN™ Probes and MPI's extensive expertise in...

Continue Reading
Passage Bio's Gene Therapy Strategy: Hope for Dementia Treatments

Updated Category News Views 76

Promising Advances in Gene Therapy Recently, Passage Bio, Inc. (NASDAQ: PASG), a pioneering company in genetic medicine, showcased groundbreaking preclinical and interim clinical results for its gene therapy product, PBFT02. This was presented at a major congress focused on gene and cell therapy. Designed specifically to target frontotemporal dementia associated with GRN...

Continue Reading